Systems include a receiving port configured to receive a cartridge configured to store a material capable of being aerosolized, a sensor configured to generate one or more measurements based on ambient conditions of a housing, an aerosolizer configured to aerosolize the material in response to receiving a signal, and a controller comprising one or more processors configured to generate the signal provided to the aerosolizer, and further configured to control operation of the aerosolizer via the signal.

Art Non-Fungible Tokens (NFTs) are typically associated with the ownership of the digital art. NFTs can be used in the field of tattooing to manage a tattoo client, art generation, art conversion into tattoo instructions, manage payment of stakeholders, allow a client to buy and sell tattoos in a secondary market, book/manage tattoo sessions, or combinations thereof. An NFT structure allows for the certification of ownership. For the context of tattooing, a smart contract may be used to track ownership of the digital design rendition of the tattoo and tattooing information. The NFT smart contract may contain the rights for the execution of the tattoo, which may allow one or many applications of a tattoo rendition of the NFT digital design, such right being consumed in the process of successive executions until the NFT may not contain any rights associated with tattooing.

A drug delivery device and related method of operation of a drug delivery device is described that includes a housing, a reservoir removably disposed within the housing and having a sidewall defining an interior for containing a drug, a temperature sensor that is configured to measure a current temperature relating to at least one of the reservoir, the sidewall of the reservoir, the housing, or the drug, and an output device that is configured to output data relating to the current temperature.

Environmental characteristics of habitable environments (e.g., hotel or motel rooms, spas, resorts, cruise boat cabins, offices, hospitals and/or homes, apartments or residences) are controlled to eliminate, reduce or ameliorate adverse or harmful aspects and introduce, increase or enhance beneficial aspects in order to improve a “wellness” or sense of “wellbeing” provided via the environments. Control of intensity and wavelength distribution of passive and active Illumination addresses various issues, symptoms or syndromes, for instance to maintain a circadian rhythm or cycle, adjust for “jet lag” or season affective disorder, etc. Air quality and attributes are controlled. Scent(s) may be dispersed. Hypoallergenic items (e.g., bedding, linens) may be used. Water quality is controlled. Noise is reduced and sounds (e.g., masking, music, natural) may be provided. Passive and active pathogen controls are employed. Controls are provided for the occupant and/or facility personnel, as is instruction, and surveys, including assessing wellness.

A medical device includes a first housing portion (FHP) and a second housing portion (SHP) configured to be to be movable relative to each other from a first position to operatively engage at a second position to couple at least one of a drive device and a needle-inserting device supported by one of the FHP and the SHP to a reservoir supported by the other of the FHP and the SHP. Electronic circuitry configured to detect at least one of a first magnetic interaction between a magnet and at least one of a first magnetically attractive material and a first magnet-responsive device and a second magnetic interaction between the magnet and at least one of a second magnetically attractive material and a second magnet-responsive device, and to provide a signal or a change in state in response to detecting at least one of the interactions.

A portable modular assistive device for storing, measuring, drawing and administering liquid injectable medication or other fluids from a vial and syringe, specifically to insulin for consumers and medical professionals in homes, while traveling and in medical facilities, having means to allow users to quickly, securely, easily and accurately measure and draw the desired amount of insulin and then administer the medication. The device is a portable syringe guide and vial holder comprising a horizontal elongated stabilizer made of rigid light-weight material with high tolerance and low friction, a rigid liquid medication vial protector at one end; a rigid movable syringe carriage with an opening on the top side to firmly hold the assembled syringe and needle to perfectly align the needle to the center section of the rubber top of the vial; a flexible expandable color-coded security strap; a flexible expandable color-coded resistance spacer ring, a removeable adjustable magnifier and calibrator bar, a rigid end cap at the other end of the horizontal stabilizer, with said holder having means to allow users to transport said holder in a pocket or pouch without risk of spillage from the vial, dislodging the components or damage to the vial, needle or syringe. Thus, a considerably more versatile, cost-effective, durable and efficient syringe guide and vial holder is provided that can accommodate a plurality of syringe and needle sizes as well as various liquid medications and other fluids in vials in the first embodiment as well as in other embodiments with ease of tracking quantities, contents, sizes and locations of a variety of vials, syringes and needles.

A method for functional testing of aerosol provision devices may include performing a functional state transition test of a power unit. The functional state transition test of the power unit may include extracting a unique identifier from the power unit of an aerosol provision device responsive to operable coupling of the power unit to a test fixture, determining a transition code based on the unique identifier, providing the transition code to the power unit via the test fixture to transition the power unit from an initial state to a transitioned state, and transitioning the power unit to the initial state.

A medicament delivery device is presented having a front-end device with a front-end housing and a delivery member cover that moves along a longitudinal axis between an extended position and a retracted position relative to the front-end housing, and a medicament container holder arranged in the front-end housing that receives a medicament container; and a reusable base device that is detachably connected to the front-end device, the base device has a plunger, a motor to drive the plunger inside the front-end housing, and wherein the motor drives the plunger from a second end position back to an initial end position, and a motor switch having a first switch position that changes to a default switch position by displacement of the delivery member cover when the delivery member cover is moved back from a retracted position to an extended position causing the motor to rotate in a reverse direction and drive the plunger from the second end position to the initial end position.

A injection site information cap includes a housing, a cover portion, an engagement portion configured to couple to and cover an injection port of an injection site, and at least one information element on the cover portion that is positioned to be automatically sensed by at least one sensor of the injection site when the engagement portion is coupled to or is being coupled to the medication injection port. Related apparatus, systems, and techniques are also described.

A syringe or medical device, especially adapted and suited for use with children, having a label with non-transparent and transparent portions positioned on the syringe or medical device so as to avoid covering measurement graduations or indicia needed by a medical practitioner for performing a medical procedure, such as an injection or blood collection, and using attention grabbing graphic images on the non-transparent portion of the label for distracting the patient's attention from fluids and/or hypodermic needles involved in the medical procedure.